Yatharth Hospital And Trauma Care Services Limited · NSE:YATHARTH
Yatharth Hospital And Trauma Care Services — Investor Presentation (November 2024)
31 slides from Yatharth Hospital And Trauma Care Services's investor presentation, Nov 26, 2024
Slide 1: Exchange filing cover letter
November 26, 2024 The Listing Department Dept. of Listing Operations National Stock Exchange of India Limited BSE Limited, Exchange Plaza, 5th Floor, Plot No. C/1 P J Towers, Dalal Street, G Block, Bandra-Kurla Complex, Bandra (E) Mumbai -400001, India Mumbai – 400 051 Symbol: YATHARTH Scrip Code: 5
Slide 2: Corporate Presentation November 2024
Corporate Presentation November 2024
Slide 3: Disclaimer
Disclaimer This presentation has been prepared for general information purposes in respect of Yatharth Hospital and Trauma Care Services Limited (“Company”) together with its subsidiaries (together, with the Company, the “Group”) only, without regard to any specific objectives, suitability, financia
Slide 4: Disclaimer
Disclaimer This presentation is not a prospectus, a statement in lieu of a prospectus, an offering circular, an advertisement or an offer document under the Companies Act, 2013, as amended, the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, a
Slide 5: Overview
Overview
Slide 6: Super specialty hospital in North India
Super specialty hospital in North India One-stop destination for patient needs providing all levels of 7 10 87% healthcare services from primary to tertiary Hospitals(1) Center of Excellence Beds in Metros(1) 2019 Noida Extension 2024 450 beds Model Town, Delhi ~300 beds 2013 2,300+ Rs. 30,597 61% B
Slide 7: Our Journey
Our Journey Growing presence across regions and services Established our first Expansion of our first Acquisition of 4th hospital - Acquired 5th hospital – hospital in Greater hospital, Greater Noida Jhansi Orchha hospital 200 beds in Gr. Faridabad; Noida hospital, to 400 beds adding 305 beds, pursu
Slide 8: Our Hospitals
Our Hospitals Built on foundation of talent, trust, technology, service and infrastructure Diversified revenue mix Greater Noida Jhansi - Greater across hospitals Hospitals Noida Noida Extension Orchha Faridabad (H1 FY25) Year of Operation 2010 2013 2019 2022 2024 Faridabad Jhansi- 3% Beds Capacity
Slide 9: Our Hospitals
Our Hospitals 66% Occupancy Greater Noida Provides a wide spectrum of super specialty services in the field of 2010 Incorporated Rs.34,444 ARPOB (1) cardiology, cardiovascular and thoracic surgery, neurology, 400 Beds; 112 ICU Beds neurosurgery, urology, nephrology, oncology, gastroenterology etc. 4
Slide 10: Our New hospitals
Our New hospitals 47% Jhansi – Occupancy Hospital in Jhansi-Orchha-Gwalior region, has Orchha infrastructure to operate all the major super specialties Rs.12,397 ARPOB(1) 2022 Acquisition Acquired in FY22 305 Beds; 76 ICU Beds 3.82 days ALOS(2) 28% Built 3 years ago with latest facilities on a 1.25-
Slide 11: Operational Parameters
Operational Parameters Occupancy (%) IPD/OPD Revenue (Rs. Mn) IPD Revenue OPD Revenue 6,705 5,203 819 4,009 4,296 684 61% 506 50% 54% 546 45% 5,886 4,519 3,790 3,464 FY22 FY23 FY24 H1FY25 FY22 FY23 FY24 H1FY25 ARPOB(1) (Rs.) ALOS(2) (days) 28,571 30,597 23,511 26,538 5.20 4.78 4.32 4.42 FY22 FY23 FY
Slide 12: Financial Performance
Financial Performance Revenue (Rs. Mn) EBITDA(1) (Rs. Mn) & EBITDA%(2) 1800 PAT (Rs. Mn) & PAT%(3) 21% 20% 19% 1600 18% 2300 2295 30% 2290 2285 2280 2275 2270 2265 2260 2255 2250 2245 2240 2235 2230 2225 29% 2220 2215 2210 12.6% 17.1% 2205 2200 11.0% 17% 14.3% 219 5 27.6% 25.7% 25.2% 219 50 26.8% 21
Slide 13: Peer Comparison
Peer Comparison 29.17% 24.56% 22.65% 22.54% 21.91% 20.32% Revenue 16.33% 14.57% 13.96% 10.39% CAGR (FY 22-24) Aster Medanta KIMS Jupiter Paras Narayana Max Apollo Fortis 27.80% 26.83% 25.64% 25.29% 24.11% 22.96% 18.39% 15.62% OPBDIT 12.54% 10.54% Margin(1) (FY24) Max KIMS Medanta Jupiter Narayana Fo
Slide 14: Board of Directors
Experienced board and leadership team Promila Bhardwaj Dr. Ajay Kumar Tyagi Independent Director Chairman & Whole-time Director 35+ yrs of experience 17+ yrs of experience Bachelor of arts, Master’s of arts in English, philosophy in social Bachelor of medicine, surgery, and diploma in orthopaedics s
Slide 15: Industry Overview
YATHARTH ie dealt oh or eo cee
Slide 16: Healthcare Delivery Market in India is at Nascent stage
Healthcare Delivery Market in India is at Nascent stage Indian hospital market to grow at a CAGR of 10-12% to reach INR 10tn by FY28 Globally India has one of the lowest bed density/10,000 population 70 (INR tn) 50 9.4-9.8 27 6.3 2.6 26 3.9 1.8 25 1.3 7.2 24 4.5 2.6 20 FY19 FY24E FY28P 15 IPD OPD 9
Slide 17: North India - Underserved market with huge growth potential
North India - Underserved market with huge growth potential North India hospital market is expected to grow at a CAGR of 12-14%... …Growing at a faster rate than the overall industry (INR tn) (INR tn) 9-11% 10-12% 3.9 6.3 9.4-9.8 3.1-3.2 10-12% 11-13% 22.5-23.5% 22-24% 22-25% 9-11% 10-12% 11.5-12.5%
Slide 18: Growth Strategy
Growth | Strategy
Slide 19: Core strategies driving growth
Core strategies driving growth Optimizing Infrastructure Enhancing occupancy and ARPOB across our hospitals 01 Capacity Addition 02 Greenfield and brownfield expansion Leverage Technology 03 Advanced and high-end medical equipment and technology 04 Clinical Expertise Attracting best talent to drive
Slide 20: Optimizing existing infrastructure
Optimizing existing infrastructure Mature hospitals New hospitals Total Occupancy (%) 67% 63% 61% 55% 54% 50% 50% Improve 45% 42% Diversifying customer specialties service 23% 8% NM FY22 FY23 FY24 H1FY25 Our 5-fold approach to optimize 34,049 existing infra 29,646 30,597 Optimized Enhanced care 28,5
Slide 21: Expanding specialties across hospitals
Expanding specialties across hospitals Diverse mix of specialties at all hospitals Noida extension hospital registered highest share of super specialties H1 21% 12% 10% 10% 10% 8% 7% 6% 5% 4% 3% FY2025 Pediatrics 3% Oncology Pulmonology 18% 5% Gynecology 5% FY2024 28% 10% 4% 10% 10% 7% Orthopedics,
Slide 22: Capacity addition - greenfield and brownfield expansion
Capacity addition - greenfield and brownfield expansion Capacity addition trend and roadmap ahead Operational Beds New bed addition Current Bed Capacity Acquired in Acquired in Oct-24 May-24 Oct-24 Apr-22 May-19 • Acquired super specialty hospital in Model Town, New Delhi, with an expandable capacit
Slide 23: Expanding footprints in New Delhi market, with ~300 beds
Expanding footprints in New Delhi market, with ~300 beds Established Multi-specialty hospital Established in 2019 Expandable to 300+ Beds ❖ Successful bid for MD City Hospital in Delhi through the e-auction process under the Acquisition Cost ~Rs. 160 crore SARFAESI Act, 2002 ❖ The hospital cater a l
Slide 24: Acquiring majority stake in 400-bedded Faridabad hospital
Acquiring majority stake in 400-bedded Faridabad hospital Yet to commence Multi-specialty hospital Built on approx. 2 Acre land Proposed Capacity 400 Beds ❖ Strategic collaboration agreement for ~60% stake acquisition in ~400 bed-hospital in Faridabad ❖ Hospital valued at enterprise value of Rs. 152
Slide 25: Advanced medical equipment and technology
Advanced medical equipment and technology • Hospitals are equipped with machines and devices with sophisticated technology • Strive to introduce medical technology and state-of-the-art equipment Complex Kidney, Liver & Bone Robotic Surgeries – Marrow Transplant DaVinci, Mako & Cuvis Radiation Oncolo
Slide 26: Attracting talent to drive super specialties
Attracting talent to drive super specialties Strategic initiatives aimed to ease attrition Integrating talent from First mover advantage in allied workforce building out network across Tier II/III cities ❑ Applied DNB program across 8 specialties in 2 of the hospitals ❑ DNB program to reduce attriti
Slide 27: Annexures
YATHARTH Bip eres me at
Slide 28: Awards and Accreditations
Awards and Accreditations 2020 2021 2022 2023 2024 ➢ Awarded 1st in ➢ Covid Thank You award ➢ 5-star grading by ➢ Awarded UP Ratan ➢ Awarded Best Brand for Swachhta Ranking (for by Niva Bupa Infomerics Analysts & Samman by Dainik Excellence in Healthcare quarter ended Sep 2019) ➢ Accreditation from
Slide 29: Profit & Loss Summary
Profit & Loss Summary Particulars (Rs Mn) H1 FY25 FY24 Revenue from Operations 4,296 6,705 Medical Consumables & Pharmacy 900 1,333 Employee Expenses 761 1,170 Other Expenses 1,552 2,403 EBITDA 1,083 1,799 EBITDA Margin % 25.2% 26.8% Depreciation and amortisation 274 293 Financial Cost 45 94 Other I
Slide 30: Balance Sheet
Balance Sheet Particulars (Rs Mn) Sep-24 Mar-24 Particulars (Rs Mn) Sep-24 Mar-24 Shareholders Equity 9,323 8,743 Fixed Assets (incl. Goodwill) 5,090 4,405 Borrowings 896 831 Right to Use Assets 4 14 Lease Liabilities 5 16 Financial Assets 128 243 Trade Payables 289 292 Inventories 143 81 Other fina
Slide 31: Thank You
Thank You Yatharth Hospital & Trauma Care Services Ltd Investor Relations Contact Mr. Neeraj Vinayak, Head – Strategy and Investor Relations investor.relations@yatharthhospitals.com CIN: L85110DL2008PLC174706 www.yatharthhospitals.com
Yatharth Hospital & Trauma Care Services — Investor Presentation (November 2024) on 6ix